Professional Associations

This page includes news coverage of medical associations and medical societies. Use these links to find focused news coverage from specific organizations: Cardiology Associations, Healthcare Associations, Radiology Associations.

RSS icon
cardiologists heart doctors heart research heart data

Colchicine reduces risk of some TAVR complications

Giving colchicine to patients prior to TAVR may reduce the risk of certain conduction disturbances, according to new research published in the Journal of the American Heart Association. It does not, however, improve survival.

Video with former ACC president Kim Williams, MD, discusses a heart screening outreach program he created in low-income Louisville neighborhoods.

Successful outreach program brings heart screenings to underserved communities

Former ACC president Kim Allan Williams Sr., MD, shared his experience bringing helpful heart screenings to low-income neighborhoods. "You've got to be willing to go out and find where the patients are," he said. 

American Medical Association (AMA) Board of Trustees Member Scott Ferguson, MD, FACR, a diagnostic radiologist, discusses how and why physicians are opting out of Medicare because the payments no longer are covering their costs. Currently, the Centers for Medicare and Medicaid Services (CMS) say about 50,000 doctors have opted out of the Medicare program, or about 5% of U.S. physicians.

Why more physicians are opting out of Medicare

American Medical Association (AMA) Board of Trustees Member Scott Ferguson, MD, FACR, discusses how and why physicians are opting out of Medicare because the payments no longer are covering their costs. 

pharmaceutical drug approval process

New drug candidate for AFib fails in first-in-human trial—in fact, it made matters worse

Researchers had thought 2-HOBA might reduce the risk of AFib recurrence after catheter ablation procedures. What they found, however, was that treatment with the compound was actually harmful for patients instead of helpful. 

Alan Matsumoto, MD, FSIR, FACR, FAHA, chairman of the American College of Radiology Board, professor of radiology and chair of the Department of Radiology, University of Virginia, Charlottesville, explains ACR support for the Texas Medical Association lawsuit three (TMA3) against the Department of Health and Human Service, because insurance companies are using the provisions of the law to to underpay providers for patient care.

ACR says insurance companies gaming the No Surprises Act with ghost rates

Alan Matsumoto, MD, chair of the American College of Radiology, discusses rad support for a Texas Medical Association lawsuit against the federal government. 
 

John D. Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains when patients are best served with coronary artery bypass graft (CABG) surgery rather than percutaneous coronary intervention (PCI).

How to choose between CABG and PCI when treating coronary artery disease

John Puskas, MD, chief of cardiothoracic surgery at Emory University Hospital Midtown, noted that both treatment options have their own benefits. It often depends on the patient's age and comorbidities, though there are other factors to consider as well. 

Joshua Joseph, MD, MPH, FAHA an expert in Cardiovascular-Kidney-Metabolic (CKM) syndrome, associate professor of internal medicine, and the Endowed Professor for Research in Internal Medicine in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University Wexner Medical Center, explains the CKM advisory from the American Heart Association designed to help define and stage the disease. CKM has seen a large amount of growing interest from cardiologists in recent years.

Interest rising in CKM syndrome as connections become clearer

Cardiovascular-kidney-metabolic (CKM) syndrome is a popular research topic among cardiologists, highlighting just how closely obesity, type 2 diabetes, chronic kidney disease and cardiovascular disease are related to one another. Joshua Joseph, MD, spoke to Cardiovascular Business about this ongoing trend.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Complications after intravascular lithotripsy are rare, real-world data confirm

Shockwave Medical, now a part of Johnson & Johnson MedTech, has consistently been found safe for patients. However, many previous clinical trials excluded high-risk patients, making it important to track real-world outcomes as time goes on.

Displaying 113 - 120 of 2386
Design by Adaptive Theme